SCHEMBL30166161

SCHEMBL30166161

C/C(=N\[S@+]([O-])C(C)(C)C)c1nccc2ccccc12

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2C19 P33261 1/20 0.40
CNR2 P34972 5/20 0.39
CYP2A6 P11509 1/20 0.39
PLAU P00749 2/20 0.37
PLG P00747 1/20 0.37
CFTR P13569 1/20 0.36
GOPC Q9HD26 1/20 0.36
RAB9A P51151 1/20 0.36
F12 P00748 1/20 0.36
NCF1 P14598 1/20 0.36
NOS3 P29474 1/20 0.36
NOS1 P29475 1/20 0.36
NOS2 P35228 1/20 0.36
BACE1 P56817 1/20 0.36
FLT3 P36888 1/20 0.35
HRH4 Q9H3N8 1/20 0.35
LMNA P02545 1/20 0.33
GPR3 P46089 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23898793 1.00 TSHR (0.40) TSHRCYP3A4CYP2C19CNR2CYP2A6
SCHEMBL25264654 1.00 TSHR (0.40) TSHRCYP3A4CYP2C19CNR2CYP2A6
SCHEMBL25184266 1.00 TSHR (0.40) TSHRCYP3A4CYP2C19CNR2CYP2A6
SCHEMBL31409963 0.77 PLAU (0.38) PLAUGPR3POLB
SCHEMBL1590559 0.77 NR4A1 (0.40) CNR2RAB9ALMNAGPR3KMT2A
SCHEMBL1590558 0.77 NR4A1 (0.40) CNR2RAB9ALMNAGPR3KMT2A
SCHEMBL1590555 0.77 NR4A1 (0.40) CNR2RAB9ALMNAGPR3KMT2A
SCHEMBL12702465 0.77 NR4A1 (0.40) CNR2RAB9ALMNAGPR3KMT2A
SCHEMBL8564181 0.76 CASP3 (0.49) TSHRCYP3A4CYP2C19CNR2CYP2A6
SCHEMBL19837744 0.75 NCF1 (0.36) CYP3A4RAB9ANCF1LMNAGPR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4126848-A1 N-HETEROARYLALKYL-2-(HETEROCYCLYL AND HETEROCYCLYLMETHYL) ACETAMIDE DERIVATIVES AS SSTR4 AGONISTS Takeda Pharmaceutical Company Limited (JP) 2023-02-08 EP disclosed